Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series

Figure 1

Representative photographs of vitiligo lesions shown at baseline (a) and following tofacitinib treatment with NB-UVB phototherapy after 5 months (b) and 7 months (c).

(a)

(b)

(c)